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, showing widespread transgene expression in the cerebellum, a structure that contains no detectable HSD2 protein or mRNA in adult animals (3, 8, 9) . Furthermore, the subjective intensity ratings provided in Table 1 indicate that transgene expression was found in a potpourri of similarly unexpected brain sites, including the external cuneate nucleus (rated "ϩϩϩϩ"), pontine nuclei ("ϩϩϩϩ"), "Hypothalamic region" ("ϩϩ/ϩϩϩ") and "Thalamic nuclei" ("ϩϩ/ϩϩϩ").
A likely explanation for these profound discrepancies is that most Cre-mediated recombination in the brain occurred early in development, in a pattern reflecting the more widespread HSD2 expression found in embryos (1, 8) . Most of this developmental HSD2 expression is only transient and disappears shortly after birth in the brain and certain other tissues (1, 8) . Even transitory expression of Cre recombinase, however, will permanently activate transgene expression, which will then persist in cells that stop expressing HSD2 (and in any of their mitotic progeny). Given the extensive perinatal pruning of HSD2 expression (1, 8) , most of the transgene expression in a mature mouse would then demarcate cells that no longer express HSD2 and are, therefore, no longer protected from glucocorticoids.
Thus, in tissues like the brain, the Cre-transgenic mice developed by Naray-Fejes-Toth and Fejes-Toth (5) may not be useful for selectively studying aldosterone-sensitive cells in a mature animal. Demonstrating Cre or HSD2 expression in the brains of adults from this strain could help in evaluating this possibility. Alternatively, these mice may prove useful for studying the role of HSD2 during development. For example, protection from glucocorticoids may be uniquely important for the development of many of the hindbrain sites listed in Table  1 (external granule layer of the cerebellum, pontine nuclei, reticular formation, cochlear nuclei, lateral reticular nucleus, external cuneate nucleus), which share a common origin in the proliferating neuroepithelium of the rhombic lip (11) .
In summary, although the major anatomic discrepancies listed here were neither acknowledged nor addressed by NarayFejes-Toth and Fejes-Toth (5), their article should not be misinterpreted as evidence for a broader pattern of HSD2 expression in the brain than that supported by existing neuroanatomic data (3, 8, 9) . The formidable technical challenge of creating such a potentially powerful transgenic tool does not justify a disregard for clear-cut inconsistencies between transgene expression and an established pattern of gene expression in normal animals.
